Caribou Biosciences, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Caribou Biosciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $12.36 million for the year ending 2025.

  • Caribou Biosciences, Inc. showed a decrease of -24.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Caribou Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), Caribou Biosciences, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 69.9%.
  • Historical annual values: Fiscal year 2025: $12.36 million | Fiscal year 2024: $16.29 million | Fiscal year 2023: $51.16 million | Fiscal year 2022: $58.34 million | Fiscal year 2021: $240.42 million | Fiscal year 2020: $15.95 million | Fiscal year 2019: $41.07 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: